Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2026-02-05 @ 3:35 PM
Study NCT ID:
NCT04752566
Status:
COMPLETED
Last Update Posted:
2025-09-08
First Post:
2021-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization: